M. Calverley

发表

20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses.

L. Binderup, K. Hansen, S. Latini, 1991, Biochemical pharmacology.

Analysis of Vitamins D, Their Metabolites and Analogues

Glenville Jones, H. Makin, M. Calverley, 2010 .

Novel side chain analogs of 1α,25-dihydroxyvitamin D3: design and synthesis of the 21,24-methano derivatives

M. Calverley, 2001, Steroids.

Emerging drugs in psoriasis

R. Gniadecki, M. Calverley, 2002, Expert opinion on emerging drugs.

Trends and developments in the pharmacological treatment of psoriasis.

C. Zachariae, R. Gniadecki, M. Calverley, 2002, Acta dermato-venereologica.

In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity.

G. Jones, H. Makin, D. Trafford, 1993, The Journal of biological chemistry.

In vitro metabolism of calcipotriol (MC 903), a vitamin D analogue.

L. Binderup, N. Andersen, H. Sørensen, 1990, Biochemical pharmacology.

Different Mechanisms of Hydroxylation Site Selection by Liver and Kidney Cytochrome P450 Species (CYP27 and CYP24) Involved in Vitamin D Metabolism (*)

F. Dilworth, R. Kremer, Glenville Jones, 1995, The Journal of Biological Chemistry.

Synthesis of mc 903, a biologically active vitamin D metabolite analogue

M. Calverley, 1987 .

Increased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding.

F. Dilworth, G. Jones, H. Makin, 1994, Biochemical pharmacology.

Evidence for the activation of vitamin D compounds in the skin by side-chain hydroxylation.

R. Gniadecki, M. Calverley, 1998, Pharmacology & toxicology.

Chloroformate ester-induced reductive 1,2-bond cleavage of some 1,2,3,4-tetrahydro-β-carboline derivatives

M. Calverley, 1982 .

7 – VITAMIN D

Glenville Jones, M. Calverley, 1992 .

Metabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side-chain.

F. Dilworth, G. Jones, H. Makin, 1997, Biochemical pharmacology.

In vitro metabolism of the anti-psoriatic vitamin D analog, calcipotriol, in two cultured human keratinocyte models.

R. Kremer, G. Jones, S. Strugnell, 1994, The Journal of biological chemistry.

The Seleno-Acetal Route to Side-Chain-Modified 1α-Hydroxy-Vitamin D Analogues: Synthesis of Three C23-Metabolites, Including Calcitroic Acid

M. Calverley, 1990 .

The Seleno-Acetal Route to Side-Chain-Modified 1α-Hydroxy-Vitamin D Analogues: Stereoselective Synthesis of the New 22Z Isomer of MC 903 (Calcipotriol)

M. Calverley, 1990 .

Reductive alkylation of a selenoacetal in the elaboration of steroid side chains: Stereochemistry and application in a synthesis of 1α-hydorxyvitamin D3☆

M. Calverley, 1987 .

Polyclonal antibodies to EB1089 (seocalcitol), an analog of 1α,25-dihydroxyvitamin D3☆

F. Björkling, P. Kaastrup, E. Binderup, 2001, Steroids.

A dialogue on analogues Newer vitamin-D drugs for use in bone disease, psoriasis, and cancer

Glenville Jones, M. Calverley, 1993, Trends in Endocrinology & Metabolism.

SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1a-HYDROXYLATED VITAMIN D ANALOGUES WITH POLY-UNSATURATED SIDE CHAINS

L. Binderup, E. Binderup, M. Calverley, 1991 .

Metabolism of the antiproliferative vitamin D analogue, EB1089, in a cultured human keratinocyte model

Glenville Jones, H. Makin, D. Trafford, 1995 .

Polar metabolites of dihydrotachysterol3 in the rat. Comparison with in vitro metabolites of 1 alpha,25-dihydroxydihydrotachysterol3.

G. Jones, H. Makin, D. Trafford, 1992, Biochemical pharmacology.

Metabolism of a cyclopropane-ring-containing analog of 1 alpha-hydroxyvitamin D3 in a hepatocyte cell model. Identification of 24-oxidized metabolites.

G. Jones, S. Strugnell, M. Calverley, 1990, Biochemical pharmacology.

The metabolism of dihydrotachysterols: Renal side chain and non-renal nuclear hydroxylations in vivo and in vitro

G. Jones, H. Makin, D. Trafford, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

1α,24S-dihydroxy-26,27-cyclo-22-yne-vitamin D3: the side chain triple bond analogue of MC 903 (Calcipotriol)

M. Calverley, Claus Bretting, 1993 .

Synthesis and biological evaluation of MC 1357, a new 20-epi-23-oxa-1α,25-dihydroxy-vitamin D3 analogue with potent non-classical effects

L. Binderup, M. Calverley, 1993 .

Synthesis of MC 903, a Biologically Active Vitamin D Metabolite Analogue.

M. Calverley, 1988 .

Properties, degradation and high temperature fuel cell test of different types of PBI and PBI blend membranes

Jens Oluf Jensen, Niels J. Bjerrum, Chao Pan, 2010 .

1,4,7-TRIOXA-10-AZACYCLODODECANE AND SOME N-SUBSTITUTED DERIVATIVES; SYNTHESIS AND CATION COMPLEXING

A. Jutand, C. Enzell, J. Berg, 1982 .

Synthesis of a cation complexing doubly N,N′-bridged bis-(1,7-dioxa-4,10-diazacyclododecane)

J. Dale, M. Calverley, 1981 .

The total synthesis of (±)-C-mavacurine

M. Calverley, B. J. Banks, J. Harley-Mason, 1981 .

On the stereochemistry of the solvolytic c/d ring cleavage of the 1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a] quinolizine system

S. Quarrie, P. Edwards, M. Calverley, 1981 .

Selective N-Monomethylation of Primary Amines via N-Trialkylsilyl-Lithioamines

M. Calverley, 1983 .

A new synthesis of indolo[2,3-α]quinolizidine derivatives: a formal total synthesis of (±)-geissoschizine

P. Edwards, M. Calverley, B. J. Banks, 1981 .

Synthesis and cation complexing of N,N′-bridged bis-(1,4,7-trioxa-10-azacyclododecanes)

J. Dale, M. Calverley, 1981 .

Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line.

C. Capen, W. Kisseberth, M. Calverley, 2005, Anticancer research.

The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity.

F. Dilworth, J. Nielsen, J L Nielsen, 1997, Endocrinology.

Analysis of vitamin D, its metabolites and structural analogues

Glenville Jones, H. Makin, M. Calverley, 1995 .

New guidelines for preparation taper.

F. M. Gardner, F M Gardner, M H Parker, 1993, Journal of prosthodontics : official journal of the American College of Prosthodontists.

Removable partial denture framework try-in.

W. Nagy, M. Calverley, M. Wong, 1993, The Journal of prosthetic dentistry.

Quantitative determination of taper adequate to provide resistance form: concept of limiting taper.

F. M. Gardner, F M Gardner, M J Calverley, 1988, The Journal of prosthetic dentistry.

Synthesis and testing of 2α-modified 1α, 25-dihydroxyvitamin D3 analogues with a double side chain: Marked cell differentiation activity

K. Waku, T. Sugiura, Nozomi Saito, 2002 .

Synthesis of novel hapten derivatives of 1alpha,25-dihydroxy-vitamin D3 and its 20-epi analogue.

F. Björkling, M. Begtrup, E. Binderup, 2003, The Journal of organic chemistry.

Synthesis of 21-(3-Methylbutyl)cholest-5-ene-3β,3′,25-triol and 21-(2-Methylpropoxy)cholest-5-ene-2′,3β,25-triol, the First “Double Side Chain” Cholesterol Analogues

J. Wicha, M. Calverley, A. Kurek-Tyrlik, 1997 .

Synthesis and Testing of 2α‐Modified 1α,25‐Dihydroxyvitamin D3 Analogues with a Double Side Chain: Marked Cell Differentiation Activity.

K. Waku, T. Sugiura, Nozomi Saito, 2003 .

SYNTHESIS AND BIOLOGICAL ACTIVITY OF 22-OXA VITAMIN D ANALOGUES

L. Binderup, M. Calverley, K. Hansen, 1991 .

An allylic nucleophilic substitution reaction of 1α-hydroxyvitamin D derivatives

M. Calverley, 1986 .